Publications by authors named "Chunxi Cha"
Article Synopsis
- A recent clinical trial studied the Chinese traditional medicine Qiliqiangxin (QLQX) in patients with heart failure and reduced ejection fraction (HFrEF) to evaluate its effectiveness and safety.
- The trial involved over 3,100 patients across 133 hospitals in China and found that QLQX significantly reduced hospitalizations for heart failure and cardiovascular deaths compared to a placebo.
- Overall, while QLQX showed promising results in improving heart failure outcomes, there was no significant difference in all-cause mortality or adverse events compared to the placebo group.
